SEC Form 4 · accession 0001387131-18-001513
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis A Cannon
Director
Period of report
Apr 6, 2018
Accepted (ET)
Apr 10, 2018 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 6, 2018 | A | 4,687 | $1.36 | A | 66,955 | D | |
| Common StockF3 | holding | — | — | — | 7,557,436 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Common Stock was issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. Director Compensation Policy in lieu of the reporting person's quarterly retainer and any meeting fees of $6,375.
- F250,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- F3Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.